Tecentriq 1200mg Injection
By Tecentriq
Rx
20ml Solution for Infusion in a Vial

Composition
Atezolizumab(60mg/ml)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
July, 2025

liver
Before using Tecentriq 1200mg Injection, it's important to note that there is limited information regarding its use in patients with liver disease. It is strongly advised to consult with your doctor for guidance specific to your condition. Your healthcare provider can assess the potential risks and benefits based on your individual liver health to determine the most appropriate course of treatment.

kidney
There is limited information about the use of Tecentriq 1200mg Injection in patients with kidney disease. Please consult your doctor.

alcohol
Consult your doctor when consuming alcohol with Tecentriq 1200mg Injection.

driving
It is unknown if Tecentriq 1200mg Injection affects driving. Avoid driving if you have symptoms affecting focus and reaction times.

pregnancy
Tecentriq 1200mg Injection may not be safe during pregnancy. Limited human studies suggest possible harm to the baby. Animal studies show adverse effects. Consult your doctor for a thorough evaluation of risks and benefits before using this medication.

breastfeeding
Caution is advised when breastfeeding while using Tecentriq 1200mg Injection as it may be harmful to the baby due to potential passage of the drug into breastmilk.
Habit Forming | No |
Chemical Class | Peptides |
Therapeutic Class | - |
Action Class | Programmed Cell Death 1 (PD-1) Checkpoint Inhibitors |
₹396725
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025